David Patrick Martin
Physician in Boulder, CO
License number
Colorado 41198
Issued Date
Dec 31, 2002
Renew Date
Jun 1, 2003
Expiration Date
May 31, 2005
Type
Physician
Address
Address
1155 Alpine 320, Boulder, CO 80304
Professional information
Methods Of Using Gdnf As A Neuroprotective Agent
US Patent:
5733875, Mar 31, 1998
Filed:
May 22, 1995
Appl. No.:
8/446383
Inventors:
David Martin - Boulder CO
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 3817
US Classification:
514 12
Abstract:
The present invention is directed to the use of glial-derived neurotrophic factor (GDNF) to inhibit or prevent seizure activity. The methods of the present invention are accomplished by administering GDNF to patients having or potentially having a neurodegenerative disorder such as epilepsy. Pharmaceutical compositions containing a therapeutically effective amount of GDNF in a pharmaceutically acceptable carrier are also provided.
Method For Treating Huntington's Disease Using Glial Cell Line-Derived Neurotrophic Factor (Gdnf) Protein Product
US Patent:
5741778, Apr 21, 1998
Filed:
Mar 19, 1996
Appl. No.:
8/618543
Inventors:
David Martin - Boulder CO
Gerald D. Miller - Nederland CO
Gerald D. Miller - Nederland CO
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 4700, A61K 31685, A61F 200
US Classification:
514 12
Abstract:
Methods are provided for preventing or reducing N-methyl-D-aspartate (NMDA) receptor agonist-mediated neuronal cell death by administering a glial cell line-derived neurotrophic factor (GDNF) protein product.